TCT-528 Use of guideline directed medical therapy and outcomes in patients with high risk of bleeding undergoing percutaneous coronary intervention in contemporary clinical practice

Background Introduction: There are limited data on the uptake of guideline directed medical therapy (GDMT) and the specific impact of high bleeding risk (HBR) on ischemic outcomes following PCI. GDMT was defined as a combination of dual antiplatelet therapy, statin, β-blocker and angiotensin-convert...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B219-B219
Main Authors: Sorrentino, Sabato, Baber, Usman, Chandrasekhar, Jaya, Farhan, Serdar, Ge, Zhen, Vogel, Birgit, Sartori, Samantha, Kovacic, Jason, Moreno, Pedro, Suleman, Javed, Vijay, Pooja, Snyder, Clayton, Sharma, Madhav, Levine, Hannah, Giustino, Gennaro, Kini, Annapoorna, Sharma, Samin, Mehran, Roxana
Format: Article
Language:English
Subjects:
Angioplasty
Antiplatelet therapy
Bleeding
Cardiology
Clinical medicine
Health risk assessment
Heart attacks
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Introduction: There are limited data on the uptake of guideline directed medical therapy (GDMT) and the specific impact of high bleeding risk (HBR) on ischemic outcomes following PCI. GDMT was defined as a combination of dual antiplatelet therapy, statin, β-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use in patients with an ACC/AHA class I indication for each medication.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.699